Possible parathyroid calcium-sensing set point shift in patients undergoing maintenance hemodialysis.

IF 1.5 4区 医学 Q3 HEMATOLOGY
Masayuki Tanemoto, Takahiro Kasai, Yoshito Iida
{"title":"Possible parathyroid calcium-sensing set point shift in patients undergoing maintenance hemodialysis.","authors":"Masayuki Tanemoto,&nbsp;Takahiro Kasai,&nbsp;Yoshito Iida","doi":"10.1111/1744-9987.13982","DOIUrl":null,"url":null,"abstract":"Dear Editor, In chronic kidney disease–mineral and bone disorder (CKD–MBD), monitoring blood biochemical parameters is recommended, and albumin-corrected total serum calcium concentration (cCa) is generally used as a parameter of blood calcium [1]. However, several factors in the blood make cCa unreliable to indicate the physiological activity of blood calcium. We found six maintenance hemodialysis (MHD) patients who had hypocalcemia of cCa <8.4 mg/dL repeatedly while having plasma intact parathyroid hormone concentration (iPTH) not over the recommended range [2]. For them, calcimimetics and vitamin D analogues had not been administered. Since cCa might not have indicated the physiological activity of blood calcium, correlations between cCa, plasma ionized calcium concentration (iCa), and iPTH were examined in them. Correlations were analyzed by Pearson's correlation test in the SPSS software package (IBM Corp., Armonk, NY). Table 1 shows the characteristics and biochemical parameters of the patients. The age and dialysis vintage ranged 59–75 years and 6–92 months, respectively. Calcium bicarbonate was administered to five patients, and lanthanum bicarbonate was also administered to two of them. In one, three, and two patients, iPTH (normal range [NR]: 10–65 pg/mL) was 10–65, 65–130 and 130–260 pg/mL, respectively. In the simultaneous measurement, cCa (NR: 8.4–10.1 mg/dL), iP (NR: 3.5–5.5 mg/dL), and iCa (NR: 1.16–1.30 mmol/L) ranged 7.04–8.22 mg/dL, 3.4–7.2 mg/dL, and 0.89–1.11 mmol/L, respectively. While cCa and iCa correlated with each other (r = 0.90, p = 0.016), neither cCa nor iCa correlated with iPTH significantly (p = 0.14 and 0.09, respectively). The positive correlation between cCa and iCa suggests that cCa could indicate the physiological activity of blood calcium and be a parameter of CKD–MBD in them. While two patients had hyperphosphatemia of >5.5 mg/dL, hyperphosphatemia is an iPTH-elevating factor and would not have influenced the finding of iPTH not over the recommended range in them [3]. Thus, the finding suggests that some HD patients have iPTH not over the recommended range under hypocalcemia. The iPTH not over the recommended range under hypocalcemia would be resulted from a shift of the serum-calcium-sensing set point to a hypocalcemic state in their parathyroid. Since MHD patients with chronic hypocalcemia will have a steeper iCa increase during each dialysis session compared","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":"27 4","pages":"815-816"},"PeriodicalIF":1.5000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Apheresis and Dialysis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/1744-9987.13982","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Dear Editor, In chronic kidney disease–mineral and bone disorder (CKD–MBD), monitoring blood biochemical parameters is recommended, and albumin-corrected total serum calcium concentration (cCa) is generally used as a parameter of blood calcium [1]. However, several factors in the blood make cCa unreliable to indicate the physiological activity of blood calcium. We found six maintenance hemodialysis (MHD) patients who had hypocalcemia of cCa <8.4 mg/dL repeatedly while having plasma intact parathyroid hormone concentration (iPTH) not over the recommended range [2]. For them, calcimimetics and vitamin D analogues had not been administered. Since cCa might not have indicated the physiological activity of blood calcium, correlations between cCa, plasma ionized calcium concentration (iCa), and iPTH were examined in them. Correlations were analyzed by Pearson's correlation test in the SPSS software package (IBM Corp., Armonk, NY). Table 1 shows the characteristics and biochemical parameters of the patients. The age and dialysis vintage ranged 59–75 years and 6–92 months, respectively. Calcium bicarbonate was administered to five patients, and lanthanum bicarbonate was also administered to two of them. In one, three, and two patients, iPTH (normal range [NR]: 10–65 pg/mL) was 10–65, 65–130 and 130–260 pg/mL, respectively. In the simultaneous measurement, cCa (NR: 8.4–10.1 mg/dL), iP (NR: 3.5–5.5 mg/dL), and iCa (NR: 1.16–1.30 mmol/L) ranged 7.04–8.22 mg/dL, 3.4–7.2 mg/dL, and 0.89–1.11 mmol/L, respectively. While cCa and iCa correlated with each other (r = 0.90, p = 0.016), neither cCa nor iCa correlated with iPTH significantly (p = 0.14 and 0.09, respectively). The positive correlation between cCa and iCa suggests that cCa could indicate the physiological activity of blood calcium and be a parameter of CKD–MBD in them. While two patients had hyperphosphatemia of >5.5 mg/dL, hyperphosphatemia is an iPTH-elevating factor and would not have influenced the finding of iPTH not over the recommended range in them [3]. Thus, the finding suggests that some HD patients have iPTH not over the recommended range under hypocalcemia. The iPTH not over the recommended range under hypocalcemia would be resulted from a shift of the serum-calcium-sensing set point to a hypocalcemic state in their parathyroid. Since MHD patients with chronic hypocalcemia will have a steeper iCa increase during each dialysis session compared
维持性血液透析患者甲状旁腺钙敏感设定点移位的可能性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Therapeutic Apheresis and Dialysis
Therapeutic Apheresis and Dialysis 医学-泌尿学与肾脏学
CiteScore
3.00
自引率
10.50%
发文量
166
审稿时长
6-12 weeks
期刊介绍: Therapeutic Apheresis and Dialysis is the official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis and the Japanese Society for Dialysis Therapy. The Journal publishes original articles, editorial comments, review articles, case reports, meeting abstracts and Communications information on apheresis and dialysis technologies and treatments.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信